; Whereas the United States is the largest donor to the Global Fund to Fight AIDS, Tuberculosis and Malaria, and every $1 contributed by the United States leverages an additional $2 from other donors, as required by law; Whereas considerable progress has been made in the fight against HIV/AIDS, including a nearly 40-percent reduction in new HIV transmissions, a nearly 60-percent reduction in new HIV transmissions among children, and a reduction of over 50 percent in the number of AIDS-related deaths between 2010 and 2022; Whereas approximately 29,800,000 people had access to antiretroviral therapy in 2022, compared to only 7,800,000 people who had access to such therapy in 2010; Whereas research funded by the National Institutes of Health found not only that HIV treatment saves the lives of people living with HIV, but people living with HIV on effective antiretroviral therapy and who are durably virally suppressed cannot sexually transmit HIV, proving that HIV treatment is prevention; Whereas the CDC states that preexposure prophylaxis (PrEP) reduces HIV transmission through sexual contact by 99 percent when taken as prescribed, proving that PrEP is critical for HIV prevention; Whereas nearly 4,000,000 people globally had started taking PrEP by the end of 2022; Whereas it is estimated that, without treatment, half of all infants living with HIV will die before their second birthday; Whereas, despite the remarkable progress in combating HIV, significant challenges remain; Whereas there were approximately 1,300,000 new HIV diagnoses in 2022 globally, structural barriers continue to make testing and treatment programs inaccessible to highly vulnerable populations, and an estimated 5,400,000 people living with HIV globally still do not know their HIV status; Whereas the CDC reports that over 35,000 people were diagnosed with HIV in the United States in 2021, and 13 percent of the 1,200,000 people in the United States living with HIV are not aware of their HIV status